Related references
Note: Only part of the references are listed.The Causes and Consequences of Polyploidy in Normal Development and Cancer
Teresa Davoli et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Mitochondrial Liaisons of p53
Lorenzo Galluzzi et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Pharmacological Activation of p53 in Cancer Cells
Mohammad Athar et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Translating p53 into the clinic
Chit Fang Cheok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Mitotic catastrophe: a mechanism for avoiding genomic instability
Ilio Vitale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase
Riccardo Colombo et al.
CANCER RESEARCH (2010)
Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos
Ilio Vitale et al.
EMBO JOURNAL (2010)
Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine
Stefano Santaguida et al.
JOURNAL OF CELL BIOLOGY (2010)
Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex
Laura Hewitt et al.
JOURNAL OF CELL BIOLOGY (2010)
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
Sarah L. Thompson et al.
JOURNAL OF CELL BIOLOGY (2010)
Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Yan Degenhardt et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function
Nicholas Kwiatkowski et al.
NATURE CHEMICAL BIOLOGY (2010)
SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition
J. A. Kim et al.
ONCOGENE (2010)
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
K. G. Wiman
ONCOGENE (2010)
Chemical Genetic Inhibition of Mps1 in Stable Human Cell Lines Reveals Novel Aspects of Mps1 Function in Mitosis
Tale Sliedrecht et al.
PLOS ONE (2010)
Therapeutic targeting of p53 by small molecules
Galina Selivanova
SEMINARS IN CANCER BIOLOGY (2010)
Transcriptional Regulation by p53
Rachel Beckerman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe
S. Rello-Varona et al.
CELL DEATH & DISEASE (2010)
Targeting the cancer kinome through polypharmacology
Zachary A. Knight et al.
NATURE REVIEWS CANCER (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1
J. M. Vicencio et al.
CELL DEATH AND DIFFERENTIATION (2009)
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2009)
JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125
Miao Wang et al.
JOURNAL OF PATHOLOGY (2009)
Regulation of Kinetochore Recruitment of Two Essential Mitotic Spindle Checkpoint Proteins by Mps1 Phosphorylation
Quanbin Xu et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Cytoplasmic functions of the tumour suppressor p53
Douglas R. Green et al.
NATURE (2009)
Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
K. A. Olaussen et al.
ONCOGENE (2009)
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
Surojit Sur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Bim and Bmf Synergize To Induce Apoptosis in Neisseria Gonorrhoeae Infection
Oliver Kepp et al.
PLOS PATHOGENS (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
Sanjeev Shangary et al.
Annual Review of Pharmacology and Toxicology (2008)
Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone
Jens Hoffmann et al.
CANCER RESEARCH (2008)
Transient Nutlin-3a Treatment Promotes Endoreduplication and the Generation of Therapy-Resistant Tetraploid Cells
Hong Shen et al.
CANCER RESEARCH (2008)
Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells
Ilio Vitale et al.
CELL CYCLE (2008)
Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125
Matthew L. H. Chu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy
S. Finkin et al.
ONCOGENE (2008)
Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
Ilio Vitale et al.
PLOS ONE (2007)
Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells
Yumi Miyamoto-Yamasaki et al.
CELL BIOLOGY INTERNATIONAL (2007)
p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation
Geun-Hyoung Ha et al.
CANCER RESEARCH (2007)
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
Thibault de la Motte Rouge et al.
CANCER RESEARCH (2007)
Methods for the assessment of mitochondrial membrane permeabilization in apoptosis
Lorenzo Galluzzi et al.
APOPTOSIS (2007)
Tetraploidy, aneuploidy and cancer
Neil J. Ganem et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization
Yael Aylon et al.
GENES & DEVELOPMENT (2006)
The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function
Farid Gizatullin et al.
CANCER RESEARCH (2006)
Apoptosis regulation in tetraploid cancer cells
Maria Castedo et al.
EMBO JOURNAL (2006)
Ablation of the spindle assembly checkpoint by a compound targeting Mps1
M Schmidt et al.
EMBO REPORTS (2005)
Inhibition of c-jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M CO cycle arrest
C Kuntzen et al.
CANCER RESEARCH (2005)
Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints
AA Levesque et al.
ONCOGENE (2005)
Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis
J Gu et al.
ONCOGENE (2004)
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells
AM Mingo-Sion et al.
ONCOGENE (2004)
Inhibition of JNK2 disrupts anaphase and produces aneuploidy in mammalian cells
RA MacCorkle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation
A Tritarelli et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Kinetochore localization and microtubule interaction of the human spindle checkpoint kinase Mps1
VM Stucke et al.
CHROMOSOMA (2004)
Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125
JS Heo et al.
EMBO JOURNAL (2004)
Synthetic small inhibiting RNAs:: Efficient tools to inactivate oncogenic mutations and restore p53 pathways
LA Martinez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Quantitation of mitochondrial alterations associated with apoptosis
M Castedo et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner
O Potapova et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)